← All companies

ANVS

Annovis Bio, Inc.

ANVS NYSE Pharmaceutical Preparations EDGAR ↗

$1.72

-0.05 -2.82%

Key statistics

from XBRL data in SEC filings

Market cap

$59.6M

Revenue (TTM)

$0.00

Net income (TTM)

-$40.9M

EPS (TTM)

$-1.71

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$14.2M

Total assets

$16.2M

Gross margin

—

52-week range

$1.54 – $5.50

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 10, 2026 8-K Shareholder vote results Jun 17, 2026 8-K Entered a material agreement; Regulation FD disclosure May 20, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release) May 15, 2026 8-K Entered a material agreement; Regulation FD disclosure Apr 10, 2026 8-K Director or officer change Mar 25, 2026 8-K Results of operations (earnings release) Mar 16, 2026 10-K Fiscal year ended 2025-12-31 Mar 13, 2026 8-K Regulation FD disclosure Feb 12, 2026 8-K Regulation FD disclosure Jan 28, 2026 8-K Results of operations (earnings release) Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Entered a material agreement; Other events Oct 28, 2025 8-K Entered a material agreement; Regulation FD disclosure; Other events Oct 14, 2025 8-K Director or officer change Sep 29, 2025 8-K Director or officer change Aug 15, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Shareholder vote results Jun 23, 2025 8-K Regulation FD disclosure Jun 20, 2025 8-K Results of operations (earnings release); Director or officer change May 13, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Delisting notice or listing-rule failure; Director or officer change; Regulation FD disclosure Mar 27, 2025 10-K Fiscal year ended 2024-12-31 Mar 21, 2025 8-K Results of operations (earnings release) Mar 21, 2025 8-K Regulation FD disclosure Feb 5, 2025 8-K Entered a material agreement; Other events Feb 5, 2025 8-K Regulation FD disclosure Dec 11, 2024 8-K Entered a material agreement Dec 11, 2024 8-K Director or officer change Dec 9, 2024 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Other events Oct 15, 2024 8-K Regulation FD disclosure Sep 30, 2024 8-K Results of operations (earnings release) Aug 15, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Regulation FD disclosure Aug 6, 2024 8-K Regulation FD disclosure Jul 16, 2024 8-K Regulation FD disclosure Jul 10, 2024